House Amendment 10a
H 4300 - Session 125 (2023-2024)
Appropriations Bill, 2023-2024
View Vote History

H O U S E THIS AMENDMENT 

A M E N D M E N T  ADOPTED 

CREATEDATE \@ "MMMM d, yyyy" \* MERGEFORMAT May 9, 2023

31089603048000

    CLERK OF THE HOUSE  

014605000

Rep. HERBKERSMAN proposes the following Amendment No. to H.4300 as Passed By The House

(Doc Name h:\legwork\house\amend\h-wm\001\h2-biomedical research center.docx):

EXPLANATION: Development of biomedical research center to analyze biological pathways, networks, and molecular systems.

Amend the bill, as and if amended, Part IB, Section 33, DEPARTMENT OF HEALTH & HUMAN SERVICES, page 352, after line 35, by adding an appropriately numbered proviso to read:

/(DHHS: Biomedical Research Center) From funds appropriated, the department shall contract with South Carolina public entities that include health service districts, health authorities, or agencies to develop a biomedical research center for the purpose of analyzing biological pathways, networks, and molecular systems. The center shall perform an evaluation of gene and protein structures along with their functions, variations in sequences and their significance, interactions between genes, proteins, and the environment, and other key discreet elements of the human condition. The purpose of this initiative is the evaluation of genetic profiles and patterns associated with disease risk to establish effective detection and therapeutic responses. The ultimate goal is to transform the orientation of healthcare from current disease treatment to one of wellness and prevention.

 The center shall have or source significant relevant experience in the following areas: (1) an established medical data research Institutional Review Board (IRB) to conduct data and human test condition studies; (2) an established record of success recruiting patients to clinical trials particularly from underserved and rural areas of the state ; (3) an established model for de-identification of patient data meeting all HIPAA requirements, along with proven information technology infrastructure to gather and successfully incorporate and organize data including System and Organizational Controls 2 (SOC2) to manage information related risk; and (4) robust and documented experience in the realm of molecular medicine insights.

The department is authorized to establish necessary contract conditions, parameters, and targets. For each year that contracts are in place, the department shall provide to the Chair of the House Ways and Means Committee, Medical Military Public and Municipal Affairs Committee, State Medical Affairs Committee, and to the Senate Finance Committee a written report by January 1st describing the distribution of funds and progress made in this effort./

Amend totals and titles to conform.